Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Correction: Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial (Bmc Cancer, (2022), 22, 1, (960), 10.1186/S12885-022-09895-5)
Alireza Sadeghi
Alireza Sadeghi

Assistant Professor of Hematology &

Oncology

Department of Internal Medicine, School of Medicine

Cancer Prevention Research Center

Seyyed Al-Shohada Hospital

Isfahan University of Medical Sciences

All Documents
22. The Needs of Colorectal Cancer Patients/Survivors: A Narrative Review, Journal of Education and Health Promotion (2022)
23. Massive Splenomegaly: A Rare Presentation of Megaloblastic Anemia, International Journal of Hematology-Oncology and Stem Cell Research (2021)
47. Multiple Myeloma With Intracytoplasmic Azurophilic Granules, International Journal of Hematology-Oncology and Stem Cell Research (2019)
51. The Prevalence of Von Willebrand Disease in Patients With Menorrhagia, Journal of Isfahan Medical School (2018)